health
FDA warns GLP-1 drugs like Ozempic carry rare vision-loss risk
The FDA added a warning about a rare eye condition that can cause sudden vision loss and blindness to the labels of all GLP-1 drugs, including Ozempic, Wegovy, Zepbound and Mounjaro, after reviewing more than 125 clinical trials.